Bellevue F.(L)-B.He.Strategy B EUR/  LU1477743386  /

Fonds
NAV1/26/2023 Chg.+1.8000 Type of yield Investment Focus Investment company
238.4300EUR +0.76% reinvestment Equity Waystone M.Co.(Lux) 
     
Chart for Bellevue F.(L)-B.He.Strategy B EUR
  Name   ISIN Performance Volatility Sharpe ratio
1. Polar Capital Healthcare Opport.I GBP IE00B3NLDF60 +21.51% 19.06% 1.00
2. J.Henderson Gl.Life Sciences F.H2 IE00B8GQ0T69 +20.11% 17.84% 0.99
3. Polar Capital Healthcare Opport.R GBP IE00B3NM2Q33 +20.91% 19.05% 0.97
4. Polar Capital Healthcare Opport.GBP IE00B28YJP58 +20.91% 19.06% 0.97
5. Polar Cap.Fd.plc Health.Bl.Ch.I GBP Acc IE00BPRBXV28 +15.31% 15.70% 0.82
6. BGF World Healthscience I2 JPY LU2263536315 +19.00% 20.32% 0.81
7. JPM-Global Healthcare Fd.X(acc)JPY LU0942618132 +18.87% 21.87% 0.75
8. Candriam Equities L Oncology Impact I LU1864482515 +15.65% 17.91% 0.74
9. Candriam Equities L Oncology Impact R LU1864482945 +15.51% 17.91% 0.73
10. AXA Framlington Health R Acc GB0003506424 +15.24% 18.48% 0.69
...
91. Bellevue F.(L)-B.He.Strategy B EUR LU1477743386 +5.40% 15.96% 0.18